These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38301486)

  • 21. Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
    El Mrimar N; Belouad EM; Benaissa E; Bssaibis F; Jazouli M; El Alaoui MA; Maleb A; Elouennass M
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):134-139. PubMed ID: 38837239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colistin Dependence in Extensively Drug-Resistant
    Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia.
    D'Onofrio V; Conzemius R; Varda-Brkić D; Bogdan M; Grisold A; Gyssens IC; Bedenić B; Barišić I
    Infect Genet Evol; 2020 Jul; 81():104263. PubMed ID: 32105865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-genome sequencing for the characterization of resistance mechanisms and epidemiology of colistin-resistant Acinetobacter baumannii.
    Hahm C; Chung HS; Lee M
    PLoS One; 2022; 17(3):e0264335. PubMed ID: 35245298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.
    Bahador A; Farshadzadeh Z; Raoofian R; Mokhtaran M; Pourakbari B; Pourhajibagher M; Hashemi FB
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):24. PubMed ID: 29859115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii.
    Cheng J; Yan J; Reyna Z; Slarve M; Lu P; Spellberg B; Luna B
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.
    Sun B; Liu H; Jiang Y; Shao L; Yang S; Chen D
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32238571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptomic analysis of colistin-susceptible and colistin-resistant isolates identifies genes associated with colistin resistance in Acinetobacter baumannii.
    Park YK; Lee JY; Ko KS
    Clin Microbiol Infect; 2015 Aug; 21(8):765.e1-7. PubMed ID: 25911992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.
    Martins-Sorenson N; Snesrud E; Xavier DE; Cacci LC; Iavarone AT; McGann P; Riley LW; Moreira BM
    J Antimicrob Chemother; 2020 Jan; 75(1):60-64. PubMed ID: 31578567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic and phenotypic analyses of multidrug-resistant
    Kim M; Park J; Park W
    Virulence; 2021 Dec; 12(1):150-164. PubMed ID: 33372826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OXA-72-Mediated Carbapenem Resistance in Sequence Type 1 Multidrug (Colistin)-Resistant Acinetobacter baumannii Associated with Urinary Tract Infection in a Dog from Serbia.
    Misic D; Asanin J; Spergser J; Szostak M; Loncaric I
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760134
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii.
    Napier BA; Burd EM; Satola SW; Cagle SM; Ray SM; McGann P; Pohl J; Lesho EP; Weiss DS
    mBio; 2013 May; 4(3):e00021-13. PubMed ID: 23695834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.
    Beceiro A; Llobet E; Aranda J; Bengoechea JA; Doumith M; Hornsey M; Dhanji H; Chart H; Bou G; Livermore DM; Woodford N
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3370-9. PubMed ID: 21576434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoters of Colistin Resistance in
    Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F
    Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377
    [No Abstract]   [Full Text] [Related]  

  • 37. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.
    Durante-Mangoni E; Del Franco M; Andini R; Bernardo M; Giannouli M; Zarrilli R
    Diagn Microbiol Infect Dis; 2015 Jul; 82(3):222-6. PubMed ID: 25858028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PmrAB, the two-component system of
    Yamada N; Kamoshida G; Shiraishi T; Yamaguchi D; Matsuoka M; Yamauchi R; Kanda N; Kamioka R; Takemoto N; Morita Y; Fujimuro M; Yokota S-i; Yahiro K
    J Bacteriol; 2024 May; 206(5):e0043523. PubMed ID: 38661375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.